HAL
48
-2
HPQ
48
11
APA
39
-2
NUE
44
-2
KR
60
-3
AKAM
35
-2
MPC
46
-6
PAYX
42
-6
SJM
26
-2
VRTX
58
-2
AAP
27
6
CSCO
60
-7
EMN
46
-27
AFL
62
2
DOV
61
-14
VNO
54
-2
OMC
57
-2
MDLZ
51
-2
PG
64
-2
BEN
34
-2
HAL
48
-2
HPQ
48
11
APA
39
-2
NUE
44
-2
KR
60
-3
AKAM
35
-2
MPC
46
-6
PAYX
42
-6
SJM
26
-2
VRTX
58
-2
AAP
27
6
CSCO
60
-7
EMN
46
-27
AFL
62
2
DOV
61
-14
VNO
54
-2
OMC
57
-2
MDLZ
51
-2
PG
64
-2
BEN
34
-2
Financhill
Back

Amneal Pharmaceuticals 10K Form

Buy
67

AMRX
Amneal Pharmaceuticals

Last Price:
$8.66
Seasonality Move:
13.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMRX News And Ratings

See the #1 stock for the next 7 days that we like better than AMRX

AMRX Financial Statistics

Sales & Book Value

Annual Sales: $2.8B
Cash Flow: $95M
Price / Cash Flow: 12.75
Annual Sales: $-0.35
Price / Book: 5.62

Profitability

EPS (TTM): -0.38050
Net Income (TTM): $-116.9M
Gross Margin: $1B
Return on Equity: -587.3%
Return on Assets: -3.36%

Amneal Pharmaceuticals Earnings Forecast

Key Amneal Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 9 years for AMRX is 36.52%.
  • The Selling, General & Administrative Expenses for AMRX have been equal to 17.05% of Gross Profit Margin.
  • The Research & Development expenses have been 7.04% of Revenue.
  • The Net Earning history of AMRX is -4.18% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Amneal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMRX
CUSIP: 03168L
Website: amneal.com

Debt

Debt-to-Equity Ratio: -22.75
Current Ratio: 1.41
Quick Ratio: 0.81

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 11.1

AMRX Technical Analysis vs Fundamental Analysis

Buy
67
Amneal Pharmaceuticals (AMRX) is a Buy

Is Amneal Pharmaceuticals a Buy or a Sell?